Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells.

AIM To investigate the potential roles of Delta-like ligand 4 (DLL4) on the biological behavior of gastric cancer cells and its molecular mechanisms. METHODS A recombinant eukaryotic expression vector containing human DLL4 gene was constructed and transfected into the human gastric cancer cell line SGC7901. Clones with up-regulated DLL4 were selected and amplified. The effect of DLL4 up-regulation on gastric cancer cell growth was assessed using cell growth assay. The migration and invasion were assessed using a transwell migration assay and matrigel invasion assay. Matrix metalloproteinases were detected using the zymogram technique. Cells were implanted subcutaneously into male BALB/c nu/nu mice. Tumor volumes were then calculated and compared. DLL4 staining in the implanted tumor was performed using immunohistochemistry technique. RESULTS Growth curves over a six-day time course showed significantly promoted cell proliferation of SGC7901 cells with up-regulated DLL4. DLL4 up-regulation in SGC7901 cells promoted the migration (205.4 ± 15.2 vs 22.3 ± 12.1, P < 0.05) and invasion (68.8 ± 5.3 vs 18.2 ± 6.0, P < 0.05) in vitro and tumorigenicity in vivo (2640.5 ± 923.6 mm(3) vs 1115.1 ± 223.8 mm(3), P < 0.05). Furthermore, significantly increased mRNA level and increased secretion of matrix metalloproteinase-2 (MMP-2) proenzyme were observed in SGC7901 cells with up-regulated DLL4. However, increased MMP-9 mRNA level but decreased extracellular MMP-9 proenzyme level was observed. CONCLUSION Our observations indicated a mechanism by which activation of DLL4-mediated Notch signaling promotes the expression and secretion of MMP-2 proenzyme and influences the progress of gastric cancer.

[1]  S. Wang,et al.  Cross-talk between endothelial cells and tumor via delta-like ligand4/Notch/PTEN signaling inhibits lung cancer growth , 2012, Oncogene.

[2]  Gavin Thurston,et al.  Dll4-Notch signaling as a therapeutic target in tumor angiogenesis , 2011, Vascular cell.

[3]  A. Sood,et al.  Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer. , 2011, Cancer research.

[4]  A. Gurney,et al.  Anti-DLL4, a cancer therapeutic with multiple mechanisms of action , 2011, Vascular cell.

[5]  Minhong Yan.  Therapeutic promise and challenges of targeting DLL4/NOTCH1 , 2011, Vascular cell.

[6]  Soon-Ah Park,et al.  Detecting the Recurrence of Gastric Cancer after Curative Resection: Comparison of FDG PET/CT and Contrast-Enhanced Abdominal CT , 2011, Journal of Korean medical science.

[7]  M. Fischer,et al.  Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations. , 2011, Cancer research.

[8]  T. Dønnem,et al.  Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer , 2010, Cancer.

[9]  F. Motoi,et al.  Blockade of Delta-Like Ligand 4 Signaling Inhibits Both Growth and Angiogenesis of Pancreatic Cancer , 2010, Pancreas.

[10]  A. Harris,et al.  Vascular Biology , Atherosclerosis and Endothelium Biolog y Expression of Vascular Notch Ligand Delta-Like 4 and Inflammatory Markers in Breast Cancer , 2010 .

[11]  Zhiwei Wang,et al.  Down‐regulation of Notch‐1 and Jagged‐1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF‐κB signaling pathways , 2010, Journal of cellular biochemistry.

[12]  Hongxia Li,et al.  Zymography and reverse zymography for detecting MMPs and TIMPs. , 2010, Methods in molecular biology.

[13]  S. Fox,et al.  Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer , 2009, British Journal of Cancer.

[14]  J. Iwasaki,et al.  Anti-angiogenic therapy against gastrointestinal tract cancers. , 2009, Japanese journal of clinical oncology.

[15]  Michael F Clarke,et al.  DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. , 2009, Cell stem cell.

[16]  M. Kuo,et al.  The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. , 2009, Cancer research.

[17]  M. Mullendore,et al.  Ligand-dependent Notch Signaling Is Involved in Tumor Initiation and Tumor Maintenance in Pancreatic Cancer , 2009, Clinical Cancer Research.

[18]  Chunming Liu,et al.  KLF4 gene expression is inhibited by the notch signaling pathway that controls goblet cell differentiation in mouse gastrointestinal tract. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[19]  Li-Xuan Qin,et al.  gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. , 2009, Cancer research.

[20]  V. Yang,et al.  Notch Inhibits Expression of the Krüppel-Like Factor 4 Tumor Suppressor in the Intestinal Epithelium , 2008, Molecular Cancer Research.

[21]  G. Dotto,et al.  Notch tumor suppressor function , 2008, Oncogene.

[22]  W. Vainchenker,et al.  Distinct Effects of the Soluble Versus Membrane‐Bound Forms of the Notch Ligand Delta‐4 on Human CD34+CD38low Cell Expansion and Differentiation , 2008, Stem cells.

[23]  T. Tsujinaka,et al.  Current status of chemoradiotherapy for gastric cancer in Japan , 2008, International Journal of Clinical Oncology.

[24]  Antonio Duarte,et al.  The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching , 2007, Proceedings of the National Academy of Sciences.

[25]  M. Katoh,et al.  Notch signaling in gastrointestinal tract (review). , 2007, International journal of oncology.

[26]  Gavin Thurston,et al.  Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis , 2006, Nature.

[27]  C. Haglund,et al.  MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer , 2006, Journal of Clinical Pathology.

[28]  M. Katoh,et al.  Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. , 2006, International journal of molecular medicine.

[29]  Adrian L Harris,et al.  Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. , 2005, Cancer research.

[30]  A. Nashimoto,et al.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  H. Koeppen,et al.  Dynamics of notch expression during murine prostate development and tumorigenesis. , 2001, Cancer research.

[32]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[33]  S. Baylin,et al.  Notch signaling induces cell cycle arrest in small cell lung cancer cells. , 2001, Cancer research.

[34]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[35]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.